Study of chemo before surgery for aggressive kidney/ureter cancer
Part of Cancer clinical trials.
This study tests whether giving chemotherapy before surgery can help patients with high-grade upper tract cancer that hasn't spread. It aims to find better ways to treat this aggressive cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have a high-grade cancer in the kidney pelvis or ureter that has spread into the muscle layer or nearby lymph nodes but not to distant organs.
- You will have chemotherapy followed by surgery to remove the kidney and ureter.
- You are in generally good health (able to do light activities like walking) with normal blood and organ function.
- You do not have any infection or serious medical condition that would make chemotherapy unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy before surgery can help people with high-risk upper tract urothelial cancer (a cancer in the kidney or ureter). The goal is to see if it improves outcomes for those who are healthy enough to receive cisplatin-based chemotherapy and undergo surgery.
This Phase 3 trial studies giving cisplatin-based chemotherapy before surgery for certain newly diagnosed upper-urinary-tract urothelial cancers (kidney/ureter). It may help shrink the cancer and improve outcomes by treating microscopic disease earlier.
This trial tests whether giving radiation therapy before surgery can help people with high-risk upper tract urothelial cancer (UTUC). The goal is to improve treatment outcomes for patients who are planning to have their cancer removed.
This trial tests a combination of immunotherapy (tislelizumab) and chemotherapy (nab-paclitaxel) given before surgery for ureteral cancer. The goal is to see if the treatment shrinks the tumor and makes the surgery more effective.
This trial checks if a DNA blood test can help decide who needs extra chemo after bladder or upper urinary tract cancer surgery. It tests whether watching for cancer DNA in the blood can match patients to the right treatment.
This study checks tumor DNA found in blood and urine to see who is at higher risk of the cancer coming back after surgery. It may help doctors identify “minimal residual disease,” meaning tiny amounts of cancer that can remain after treatment.
Hear when a new Urothelial Carcinoma (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.